Structure–activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11)

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Peptides

• Publication date

  2008-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.peptides.2007.07.025PMID 17822806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.

  2006cited by this paper
• The peptidic urotensin‐II receptor ligand GSK248451 possesses less intrinsic activity than the low‐efficacy partial agonists SB‐710411 and urantide in native mammalian tissues and recombinant cell systems

  2006cited by this paper
• In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4–11) (UFP‐803)

  2006cited by this paper
• From heart to mind. The urotensin II system and its evolving neurophysiological role.

  2005cited by this paper
• Structure–activity relationship study on human urotensin II

  2005cited by this paper
• From heart to mind

  2005cited by this paper
• Architecture of the human urotensin II receptor: comparison of the binding domains of peptide and non-peptide urotensin II agonists.

  2005cited by this paper
• Structure-activity relationships and structural conformation of a novel urotensin II-related peptide.

  2004cited by this paper
• Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.

  2004cited by this paper
• From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function.

  2004cited by this paper
• Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta

  2003cited by this paper
• Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain.

  2003cited by this paper
• Structure–Activity Relationships of Human Urotensin II and Related Analogues on Rat Aortic Ring Contraction

  2003cited by this paper
• Functional and Binding Characterizations of Urotensin II-Related Peptides in Human and Rat Urotensin II-Receptor Assay

  2003cited by this paper
• The neuromedin B receptor antagonist, BIM‐23127, is a potent antagonist at human and rat urotensin‐II receptors

  2003cited by this paper
• Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II.

  2002cited by this paper
• Pharmacological characterization of SB‐710411 (Cpa‐c[D‐Cys‐Pal‐D‐Trp‐Lys‐Val‐Cys]‐Cpa‐amide), a novel peptidic urotensin‐II receptor antagonist

  2002cited by this paper
• Structural requirements at the N-terminus of urotensin II octapeptides.

  2002cited by this paper
• Design, synthesis, conformational analysis, and biological studies of urotensin-II lactam analogues.

  2002cited by this paper
• A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge.

  2002cited by this paper
• Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model.

  2002cited by this paper
• Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents

  2002cited by this paper
• A new ligand for the urotensin II receptor

  2002cited by this paper
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999cited by this paper
• Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

  1998cited by this paper
• 1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive

  1993cited by this paper
• A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis.

  1990cited by this paper
• Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

  1980cited by this paper
• Tissue sulfhydryl groups.

  1959cited by this paper

• Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth

  2019cites this paper
• New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.

  2009cites this paper
• The Urotensin II System in Ischaemic Myocardial Dysfunction.

  2008cites this paper